AmeriFlex Group’s AstraZeneca AZN Stock Holding History

AmeriFlex Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$374K	Buy	1,973 +89	+5%	+$16.7K	0.15%	133
2026 Q1	$371K	Sell	1,884 -67	-3%	-$12.9K	0.19%	115
2025 Q4	$359K	Sell	1,951 -1,945	-50%	-$341K	0.19%	114
2025 Q3	$598K	Sell	3,896 -1,183	-23%	-$179K	0.22%	86
2025 Q2	$712K	Buy	5,079 +235	+5%	+$32.9K	0.37%	56
2025 Q1	$712K	Buy	4,844 +3,631	+299%	+$525K	0.29%	74
2024 Q4	$172K	Buy	+1,213	New	+$170K	0.08%	215

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

AmeriFlex Group's AZN Position: Q2 2026 in Review

AmeriFlex Group increased its AstraZeneca (AZN) stake by 4.7% in Q2 2026, buying an estimated $16.7K and bringing the position to 1,973 shares worth $374K. The position accounts for 0.15% of the portfolio, ranked #133.

AmeriFlex Group first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $712K in Q1 2025. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

AmeriFlex Group held 1,973 shares of AstraZeneca worth $374K as of Q2 2026.
AmeriFlex Group bought 89 AstraZeneca shares in Q2 2026, an estimated $16.7K.
AstraZeneca made up 0.15% of AmeriFlex Group's portfolio in Q2 2026, its #133 holding.
AmeriFlex Group first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
AmeriFlex Group's AstraZeneca position peaked at $712K in Q1 2025.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on AmeriFlex Group's 13F filing for Q2 2026, filed 14 Aug 2026.